Kadcyla and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kadcyla (ado-trastuzumab emtansine) and Furosemide (furosemide). Common drug interactions include lacrimation increased among females and abasia among males.

The phase IV clinical study analyzes what interactions people have when they take Kadcyla and Furosemide. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Kadcyla?

Kadcyla has active ingredients of ado-trastuzumab emtansine. eHealthMe is studying from 5,813 Kadcyla users. Check the latest studies of Kadcyla.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

On Jul, 18, 2026

63 people who take Kadcyla and Furosemide together, and have interactions are studied.

Kadcyla and Furosemide drug interactions.

What are the common drug interactions of Kadcyla and Furosemide, by gender? *:

female:

Lacrimation increased
Platelet count decreased
Pneumonia
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pulmonary oedema (fluid accumulation in the lungs)
Rash pustular (redness with pustules)
Thrombocytopenia (decrease of platelets in blood)
Fatigue (feeling of tiredness)
Pleural effusion (water on the lungs)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)

male:

Abasia (inability to walk)
Acute leukaemia (blood cancer)
Hypotension (abnormally low blood pressure)
Loss of consciousness
Neuropathy peripheral (surface nerve damage)
Syncope (loss of consciousness with an inability to maintain postural tone)
Urinary tract infection
Thrombocytopenia (decrease of platelets in blood)
Chills (felling of cold)
Constipation

What are the common drug interactions of Kadcyla and Furosemide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

White blood cell count decreased
Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)
Nausea (feeling of having an urge to vomit)
Skin fissures (a crack in the skin)
Thrombocytopenia (decrease of platelets in blood)
Cerebral disorder (brain disease)
Hepatic neoplasm (liver tumour)
Neuropathy peripheral (surface nerve damage)
Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

Interstitial lung disease
Thrombocytopenia (decrease of platelets in blood)
Breast cancer
Iiird nerve paralysis (totally closed eyelid and a down and out deviation of the eye)
Lupus-like syndrome (a disease symptom matches with lupus an immune disease)
Metastases to central nervous system (cancer spreads to central nervous system)
Metastases to liver (cancer spreads to liver)
Metastases to meninges (cancer spreads to meninges)
Nausea (feeling of having an urge to vomit)
Platelet count decreased

50-59:

Neuropathy peripheral (surface nerve damage)
Neutropenia (an abnormally low number of neutrophils)
Oedema peripheral (superficial swelling)
Onycholysis (detachment of the nail from the nail bed)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Rhinorrhoea (watery mucus discharge from the nose)
Thrombocytopenia (decrease of platelets in blood)
Ascites (accumulation of fluid in the abdominal cavity)
Aspartate aminotransferase increased
Blood albumin decreased

60+:

Thrombocytopenia (decrease of platelets in blood)
Fatigue (feeling of tiredness)
Pleural effusion (water on the lungs)
C-reactive protein increased
Headache (pain in head)
Restlessness (not able to rest)
Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Nasal mucosal disorder (disease of mucous membrane)
Paronychia (infection in the tissues adjacent to a nail on a finger or toe)

What are the existing conditions these people have? *

Breast Cancer Metastatic: 27 people, 42.86%
Breast Cancer: 17 people, 26.98%
Nausea (feeling of having an urge to vomit): 8 people, 12.70%
Dyspnea (difficult or laboured breathing): 6 people, 9.52%
Skin Fissures (a crack in the skin): 5 people, 7.94%
Paronychia (infection in the tissues adjacent to a nail on a finger or toe): 5 people, 7.94%
Hypertensive Crisis: 5 people, 7.94%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 7.94%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 7.94%
Cough: 5 people, 7.94%

* Approximation only. Some reports may have incomplete information.

Do you take Kadcyla and Furosemide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously